DCF — KINGS DAUGHTERS MEDICAL CENTER
Enterprise Value: $-479.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-479.7M
Enterprise Value
$-160.4M
PV of Cash Flows
$-319.2M
PV of Terminal Value
$-514.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $558.6M | $-25.1M | -4.0% | $-48.8M | $-44.4M |
| Year 2 | $575.4M | $-20.1M | -3.0% | $-44.5M | $-36.8M |
| Year 3 | $592.7M | $-14.8M | -2.0% | $-39.9M | $-30.0M |
| Year 4 | $610.4M | $-12.2M | -2.0% | $-38.0M | $-26.0M |
| Year 5 | $628.7M | $-11.0M | -2.0% | $-37.6M | $-23.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-479.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$542.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999944686411
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5